| Financial Year |
March 31 2023 |
| Monetary Funds |
1,265,186,176.25 |
| Held-for-trading Financial Assets |
406,894,002.31 |
| Notes Receivable |
81,926,934.05 |
| Accounts Receivable |
211,150,354.47 |
| Advances to Suppliers |
18,931,997.68 |
| Other Receivables |
14,239,912.64 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
230,751,562.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
948,807.27 |
| Total Current Assets |
2,250,172,121.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
12,187,517.89 |
| Investment Properties |
111,216,971.83 |
| Fixed Assetes |
197,983,261.02 |
| Under-construction Projects |
31,794,334.36 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
67,203,481.41 |
| R&D expenses |
-- |
| Goodwill |
16,439,668.88 |
| Long-Term Deferred and Prepaid Expenses |
8,461,184.58 |
| Deferred Income Tax Assets |
13,244,215.09 |
| Other Non-Current Assets |
10,780,798.96 |
| Sub-Total of Non-Current Assets |
559,216,243.32 |
| Total Assets |
2,809,388,365.11 |
| Short-Term Loans |
180,097,782.78 |
| Trading Financial liabilities |
-- |
| Notes Payable |
101,044,907.75 |
| Accounts Payable |
184,467,887.43 |
| Accounts Received In Advance |
3,768,497.23 |
| Employee Compensation Payable |
54,932,542.50 |
| Taxes Payable |
12,692,824.09 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
36,441,288.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,632,463.55 |
| Other Current Liabilities |
58,759,582.60 |
| Sub-Total of Current Liabilities |
659,114,236.58 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
11,231,234.01 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
24,138,356.52 |
| Total Liabilities |
683,252,593.10 |
| Paid-In Capital(Or Share Stock) |
487,272,604.00 |
| Capital Surplus |
1,106,117,517.43 |
| Surplus Reserve |
173,289,857.60 |
| LESS:Treasury Stock |
151,008,090.49 |
| Undistributed Profits |
465,642,828.11 |
| Minority Stockholder's Interest |
8,135,334.96 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,118,000,437.05 |
| Owner's Equity（Stockholder's Equity） |
2,126,135,772.01 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,809,388,365.11 |
